Michael J. Higgins - 10 Oct 2024 Form 3 Insider Report for Camp4 Therapeutics Corp (CAMP)

Reporting relationship: Director
Issuer ticker: CAMP
Reported as of: 10 Oct 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 10 Oct 2024, 21:02:48 UTC
Prior SEC filing: 07 Jun 2024
Next SEC filing: 27 Mar 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Thomas Danielski, as Attorney-in-Fact

Key filing fact

Michael J. Higgins filed Form 3 for Camp4 Therapeutics Corp (CAMP) on 10 Oct 2024.

Key facts

This page summarizes Michael J. Higgins's Form 3 filing for Camp4 Therapeutics Corp (CAMP).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Oct 2024, 21:02.

Change

Previous filing in this sequence was filed on 07 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAMP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 28,739
Date: 10 Oct 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAMP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 10 Oct 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,417
Exercise price: $2.12
Footnotes: F1

CAMP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 10 Oct 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,256
Exercise price: $8.41
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option is fully vested and exercisable as of the date hereof.

Footnote F2

This option had a vesting start date of September 1, 2022 and vests in equal monthly installments over 48 months, beginning on the one-month anniversary of the vesting start date.

SEC remarks

Exhibit 24 - Power of Attorney